Paratesticular Desmoplastic Small Round Cell Tumor with Metastasis: A Report of Two Cases
Xuan Yue,Wang Jian-zhong,Ye Tian,Kun‐Jie Wang
DOI: https://doi.org/10.1016/j.kjms.2013.01.018
2013-01-01
Abstract:Dear Editor, Desmoplastic small round cell tumor (DSRCT), a rarely seen high-grade malignant neoplasm, predominantly affects young male adults and adolescents, and primarily appears at the peritoneum. It is documented that 95% of DSRCTs are located in the abdomen and pelvis, whereas in less than 5% of cases other organs may be affected [1]. Only in a little more than 10 cases, it is reported to be located primarily near the testicle. We reported two cases (a 25- and a 35-year-old male patient) who presented with a progressive enlargement of the right hemiscrotum and marked swelling in lymph nodes in the abdominal cavity and retroperitoneum. One of them had abdominal pain; neither had any previous urological symptoms. Physical examination revealed a big, elastic, firm mass about 3 cm × 4 cm in size and several small hard nodules distal to the tail of the epididymis. Ultrasonography suggested weak echo masses with abundant blood supply. Computerized tomography (CT) confirmed testicular tumors, multiple peripheral lymph nodes enlargement, and liver metastasis. Diagnosis of DSRCT was confirmed by histological and immunohistochemical examinations (Fig. 1). Fluorescence in situ hybridization (FISH) test indicated gene translocation in one case. One patient received radical testicular resection and hepatic arterial embolization with diamminedichloroplatinum, cyclophosphamide, and pirarubicin, and postsurgical chemotherapy was applied using cyclophosphamide, pirarubicin, vindesine, and dacarbazine; the other patient received only chemotherapy using cyclophosphamide, vinpocetine, and epirubicin. Prognosis for both was not satisfying. HE and immunohistochemical staining of the biopsy specimen from the testicle masses. (A) Hematoxylin and eosin staining demonstrates nest formation of the tumor cells in the collagen fibrous stroma (400×). Immunohistochemical staining is positive for (B) desmin (diffuse strong positive staining of tumor cell cytoplasm, 400×), (C) vimentin (diffuse strong positive staining of tumor cell cytoplasm, 400×), (D) neuron-specific enolase (positive staining in part of the tumor cell cytoplasm, 400×), and (E) epithelial membrane antigen (positive staining in part of the tumor cell cytoplasm, 400×). DSRCT, characterized by the formation of nests of small round cells surrounded by fibrous tissue, is an aggressive malignant mesenchymal tumor. Manifestations of DSRCTs are complicated depending on the location of the tumor, but their clinical symptoms and signs are nonspecific. Primary paratesticular DSRCT generally manifests as gradually enlarged painless scrotal masses. Ultrasonography and CT can be employed as the preferred examination methods, but the diagnosis of DSRCT still largely relies on the histopathological, immunohistochemical, and cytogenetical examinations. Histopathology and immunocytochemistry of the tumor have been well described [2]. The distinctive genetic abnormalities with a specific translocation, i.e., t (11, 22) (p13; q12), has been demonstrated as well, presenting a particular characteristic of this rare neoplasm [3]. The ideal or standardized therapeutic strategy for patients with DSRCT is still not well established. However, most scholars deem that resection and postoperative chemoradiation therapy, with or without radiation therapy, are the best therapeutic options. A complete resection is seldom possible for abdominal tumors, but it can usually be achieved for paratesticular tumors. The effect of surgical resection on survival is not clear. Systemic chemotherapy seems to be the most reasonable approach at present, especially for patients who had not undergone complete resection. The prognosis for patients with DSRCT remains very poor, especially for those with metastatic diseases—only 29% for 3-year survival and 18% for 5-year survival [4], [5]. Early diagnosis and treatment are crucial for the management of primary paratesticular DSRCT. However, recognition deficiency of this disease wildly exists. In light of this, more efforts should be made to promote the spread of recognition and managing measures to serve the patients better.